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The last decade has witnessed a quantum jump in our knowl­
edge of the chemistry of melanogenesis and the emergence of 
some understanding as to how the chemical and enzymatic 
activities are integrated and regulated at cellular level. To an 
unusual extent, most of these advances stemmed from a mo­
lecular approach involving direct analysis of natural melanins 
coupled with studies of the chemical reactivity of the putative 
intermediates under biologically relevant conditions. Thus, 
bit by bit it has been possible to reconstruct in vitro the overall 
chemical activity of melanocytes, and to identify a number of 
regulatory factors other than tyrosinase. This and other ap­
proaches, especially the molecular biology of the pigment­
related genes, have radically changed and expanded the tra-
T yrosinase holds a central position in the biosynthesis of melanins because of its ability to catalyze the first two rate-limiting reactions, namely, the hydroxyla­tion of tyrosine to dopa and its subsequent oxidation to dopaquinone. For a long time it was thought that 
the subsequent steps proceeded more or less spontaneously to give 
ultimately a dark insoluble polymer by oxidative coupling of 
various indolic intermediates, notably dopachrome and 5,6-dihy­
droxyindole (DRI). In consequence. studies aimed at understanding 
the regulation of melanogenesis in mammalian tissues were largely 
concerned with possible mechanisms of inhibition or activation of 
tyrosinase. regarded as the main, if not the sole, controlling factor. 
Such a deceptive view of melanogenesis was first overthrown in the 
late 1960s by the discovery at Naples of the pheomelanin pathway, 
which underscored the central role played by sulphydryl com­
pounds such as cysteine and/or glutathione (GSH) in pigment-cell 
metabolism [1]. A number of other factors have been since recog-
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ditional concept of melanogenesis far beyond the boundaries 
of the Raper-Mason pathway. 
Recently, I suggested an improved scheme of melanogene­
sis accounting for the formation of melanins and related prod­
ucts of melanocyte activity. The present contribution surveys 
some verifications of the predictions, and certain new break­
throughs that have been made in the understanding of the 
regulatory steps after the dopaquinone stage. It also aims to 
provide an overview of what is presently known about the 
structure of the melanin polymers, and to draw attention to 
some problems pertaining to the definition and classification 
of the various types of pigments that can be found in epider­
mal tissues.] Invest DermatoltoO:156S-161S, 1993 
nized that can affect with different modalities the chemical activity 
of epidermal melanocytes. These include i) various intracellular 
regulators of tyrosinase synthesis and processing, ii) the activity of 
auxillary enzymes, such as dopachrome tautomerase and peroxi­
dase, and iii) certain metal ions, especially copper(II) and iron(II), 
which are known to accumulate in pigmented tissues. 
It would not be realistic in this article to attempt to provide a 
blow-by-blow account of the numerous studies pertaining to mode 
of action of such regulatory factors, nor would it be necessary be­
cause a number of recent reviews are available [2 - 5]. The aim of this 
contribution is therefore illustrative rather than comprehensive 
with major emphasis on the control points after the dopaquinone 
stage. It also aims to supply an update "working" scheme of melano­
genesis that shows how the enzymatic and chemical activity are 
integrated to specify the amount and type of excretory products that 
can be formed in epidermal melanocytes. 
Main Types of Melanins A distinguishing feature of epidermal 
melanocytes lies in their ability to produce a wide range of colors, as 
seen for example in mammalian hair, which may be black, brown, 
yellow, reddish brown, or carroty red. The type of pigmentation is 
under genetic control, which in laboratory animals is known to 
involve the action and interaction of multiple genes, some of which 
have been recently cloned and identified [6-8]. However. how the 
proteins encoded by the color genes normally interact to determine 
the type of melanin that is produced by melanocytes is still little 
understood. 
Most discussions of the issue are based on the assumption that 
melanin pigmentation involves only two chemically distinct types 
of pigments, namely, the black or brown insoluble eumelanins 
(ED = good, fJ.EA.a� = black) and the alkali-soluble pheomelanins 
(qJaw� = dusky), ranging from yellow to reddish brown. This classi­
fication, however, represents an oversimplication of the actual vari­
ety of natural melanins because each of the two groups includes 
pigments with different physical and chemical properties. In most 
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cases, such differences are so subtle as to escape direct analysis, 
although some promising results have been recently obtained by 
solid phase \3C and 14N nmr spectroscopy [9]. Yet, the line broaden­
ing and the inordinate number of resonance signals make the inter­
pretation of the spectra rather challenging. Indeed, in my exp�ri­
ence, the only reliable approach at present available for classifying 
natural melanins, rests on elemental analysis and degradation exper­
iments to define the nature and origin of the main structural units of 
the pigment polymer. 
On this ground, typical eumelanins such as those of dark human 
hair and eye, appear to be polymers or, more precisely, mixtures of 
polymers consisting mainly of 5,6-dihydroxyindole units that arise 
biogenetically from tyrosine via rearrangement of dopachlome. 
There is a widening consensus that the brown "eumelanins" are 
chemically similar, but this is more a matter of surmise than experi­
mental proof. Melanosomes of brown mice are rounded rather than 
ovoid and have a characteristic disordered internal structure with 
coarse melanin granules. Multiple alleles at the brown locus are 
known, which permit the generation of a gradient of hair color 
from light to dark brown [10]. However, there is a difference of 
opinion as to whether or not the b locus - encoded protein is another 
tyrosinase-related enzyme [11], or a melanosomal-specific catalase, 
as suggested by Halaban and Moellmann [12]. Although the latter 
view is very attractive from the biochemical viewpoint, the site and 
mode of action of the brown protein have not yet been identified 
conclusively, and the question remains open at this time. 
Similar problems occur related to the structure of the lighter 
variety of melanins and consequently some disagreement of what in 
fact constitutes a pheomelanin. From a survey of the literature it 
appears that this term was first coined in 1923 by Gornitz [13] to 
differentiate the dark insoluble pigments from the alkali soluble 
ones found in the reddish feathers of domestic fowl. Later, it was 
extended to include all non-dark melanins, found in epidermal tis­
sues of avians and mammals. However, following the work at 
Naples on the sulphur-containing pigments from some types of 
reddish hair and feathers, the term pheomelanin has been applied in 
a more restricted sense to include only those that arise biogenetically 
from cysdopas. 
This state of affairs is often overlooked in accounts on melanin 
pigmentation, wherein the modem usage of the term pheomelanin, 
meaning any light-colored pigment that is soluble in dilute alkali, is 
often used. Analytical and degradative studies,· as yet incomplete, 
suggest that some of these "pheomelanin" -looking pigments are in 
fact structural variants of eumelanins arising by partial peroxidative 
cleavage of 5,6-dihydroxyindole units (unpublished results). Such a 
mechanism would be in keeping with high susceptibility of eumel­
anin polymer to hydrogen peroxide, which is likely to be formed in 
the later stages of melanogenesis (see below). Thus, in vivo modula­
tion of eumelanin color by hydrogen peroxide could provide an 
alternate mechanism for understanding the polychromy of hair 
color that otherwise would be difficult to explain-on the basis of 
only two types of pigments. 
In the light of the foregoing, it is clear that the term pheomelan­
ins is conceptually ambiguous when used in the absence of a de­
scriptive definition, which is sometimes difficult [1]. Therefore, 
until a new codified nomenclature of melanins is adopted, my sug­
gestion is to retain the name pheomelanin for the cysdopa-derived 
pigments, and use the new term "oxymelanins" to describe those 
non-dark pigments that are devoid of sulphur and are soluble in 
dilute alkali. 
An additional complication in classifying natural melanins stems 
from the occurrence in certain epidermal tissues of pigments whose 
chemical and physical properties stand in between those of typical 
eumelanins and sulfur-containingphaeomelanins. Analytical, degra­
dative, and model studies [1], as yet imperfect, would suggest that 
some of these pigments could arise biogenetically from the oxida­
tive co-polymerization of both eumelanin and phaeomelanin pre-
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Figure 1. Colorless products of melanocyte activity. 
cursors to give mixed-type melanins. However, whether they are 
heteropolymers or intimate mixtures of the two types of polymers 
awaits further investigation. 
Melanin-Related Metabolites Several studies from different 
laboratories have shown that in addition to melanins, epidermal 
melanocytes have the ability to produce a number of colorless metab­
olites (Fig 1), which are partly excreted and found in blood and 
urine [14-16]. 
One group of these metabolites includes the indolic melanogens, 
e.g., 5,6-dihydroxyindole (DHI) and 5,6-dihydroxyindole-2-car­
boxylic acid (DHICA), which have also been detected in melano­
somes and in coated vesicles of malignant melanocytes from 
Greene's hamster melanoma [17]. Like other catechols, DHI and 
DHICA are usually metabolized by a-methylation and subsequent 
conjugation with glucuronic or sulphuric acid. Comparative studies 
[14,18] have shown that, of all detectable indolic melanogens, 5-
hydroxy-6-methoxyindole-2-carboxylic acid (6HMICA) is the one 
that best reflects melanocyte activity, and can therefore be used as a 
specific marker for the follow-up of melanoma patients. 
Another group of urinary melanogens consists of the cysdopas, 
which have been extensively investigated by Rorsman and his asso­
ciates at Lund [19]. The major of these metabolites, 5-cysdopa, was 
first detected in melanoma and in the urine of a patient with pig­
mented melanoma metastases. The two other isomers of 5-cysdopa, 
namely, 2- and 6-cysdopa, have also been found in melanoma urine, 
as has also the diadduct 2,5-dicysdopa [20]. 
At one time it was thought that the urinary level of 5-cysdopa was 
related to the ability of melanocytes to form pheomelanins rather 
than eumelanins. In fact, we now know that 5-cysdopa is normally 
found in the urine of both eumelanin and pheomelanic subjects, and 
there is no substantial difference in the normal mean values between 
people of different race or complexion [16,19,21]. Notably, 5-cys­
dopa is also found, albeit in smaller amounts, in plasma and urine 
from several types of hurnan and mouse albinos, implying that it is a 
nonspecific, i.e., non-tyrosinase dependent, oxidation product of 
dopa in melanocytes [22,23]. 
Studies of the distribution of dopa and 5-cysdopa in different 
compartments of Harding Passey melanoma cells have revealed that 
the ratio cysdopas: dopa is higher in the soluble fraction than in the 
large granule fraction containing melanosomes [24]. This would 
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Figure 2. Comprehensive scheme of reaction pathways leading to melanins and related metabolites (from [1». 
suggest that a large portion of cysdopas is formed in the cytoplasm 
of the melanocytes, where it is excreted into the surrounding tissue 
fluid, thus passing to circulation. The same authors have shown that 
cysdopa is not decarboxylated in the kidney or other organs, and this 
partly explains why the ratio dopa: cysdopa is high in serum but 
very low in urine. Moreover, no conjugation of cysdopa with glucu­
ronic or sulphuric acid has been observed. These and other proper­
ties, including a high renal plasma clearance, makes cysdopa a useful 
marker of oxidative metabolism of tyrosine in mammalian tissues. 
OXIDATIVE METABOLISM OF TYROSINE IN 
EPIDERMAL MELANOCYTES 
From what has been said so far it is clear that tyrosine metabolism in 
melanocytes can give rise to a considerable range of products, some 
of which have low molecular weights and others that are polymers 
of ill-defined structure arising from the oxidation of either 5,6-di­
hydroxyindoles or cysteinyldopa-derived units. Despite the evident 
differences in molecular size and general properties, they can all be 
embraced by one biogenetic scheme in which dopaquinone is the 
key intermediate. An overall view of the possible reaction pathways 
is given in Fig 2. 
As a matter of convenience, we shall first focus on the sequence of 
reactions leading to eumelanins and related indolic metabolites. We 
shall then address the other possible route of metabolism of dopa­
quinone leading to cysdopas and the sulfur-containin� pheomelan­
ins. It should be clear however, that each of these reactlon pathways 
may proceed at least in part in parallel, as evidenced by the co-oc­
currence of 5,6-dihydroxyindoles and cysteinyldopas in subcellular 
compartments of melanocytes, as well as blood and urine of both 
eumelanic and pheomelanic subjects. 
Eumelanins and Related MetaboUtes Under conditions of 
low sulfhydryl content, as in eumelanin-forming melanocytes, 
most of the dopaquinone is converted to leucodopachrome, wh�ch 
is rapidly oxidized to dopachrome by a redox-exchange reactlon 
with dopaquinone itself, as suggested by Raper [25]. This is quite in 
accord with the redox potentials of the two coupled systems in-
volved, namely, 
i} dopa E , dopaquinone (EO = +0.511V/pH 4.6) 
and 
ii} leucodopachrome!:=:::+ dopachrome 
(EO = +0.170V/pH 4.6). 
As a result of this electrochemical-chemical-chemical system, a 
certain amount of dopa can be expected to be constantly present in 
active melanocytes, despite the fact that tyrosinase can oxidize dopa 
more rapidly than tyrosine. 
The proposed sequence of reactions leading from tyrosine to do­
pachrome have been confirmed by various groups using electroana­
lytical techniques [26], pulse radiolysis [27], and electron paramag­
netic resonance (EPR) [28]. Rate constants for the implicated 
chemical steps at different pH and temperature values have been 
calculated, as well as the activation thermodynamic parameters of 
the deprotonation of dopaquinone to dopaquinone and its subse­
quent cyclization to leucodopachrome [29]. 
Another step of melanogenesis that has been addressed in recent 
years is the rearrangement of dopachrome. When observed in vitro, 
this reaction is rather slow and leads mainly to DHI, along with 
some 50/0 of DHICA [30]. However, if dopachrome is allowed to 
rearrange in the presence of certain metal ions, commonly found in 
pigmented tissues, e.g., copper, iron, or zinc, the reaction proceeds 
very fast to give mainly DHICA rather than DHI. As a rule, the 
more active the metal on the kinetics of the reaction is, the less DHI 
is formed. A similar effect on the rearrangement of dopachrome is 
induced by a protein-regulatory factor found in a variety of mela­
notic and amelanotic melanoma cell lines, as well as in normal 
melanocyte-containing tissues [4]. 
Early attempts to characterize this dopachrome conversion factor 
(DCF) were carried out on crude cell extracts and the interpretation 
of the observed effects were not entirely unequivocal with respect to 
such parameters as the nature and molecular size of the active com­
ponent(s}, presence of metal ions, and product identification. How­
ever, subsequent studies at Yale and other laboratories have con­
firmed that DCF is a membrane-bound glycoprotein of high 
molecular weight that catalyzes the non-decarboxylative rearrange-
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ment of L-dopachrome to DHICA. Different names have been 
proposed for this enzyme, i.e., dopachrome oxidoreductase [31,32], 
dopachrome isomerase [33], and dopachrome tautomerase [34,35], 
the last being now generally accepted. 
Studies aimed at characterizing dopachrome tautomerase (DT) by 
conventional biochemical techniques have been largely unreward­
ing, but recently some useful information has been obtained by 
investigation of the melanosomal-specific proteins from melanoma 
cell extracts. One of these proteins, termed TRP2, which putatively 
maps the slaty locus on chromosome 14 in mice, shares significant 
sequence homology with tyrosinase, including a perfect conserva­
tion of the critical domains, such as putative copper- and iron-bind­
ing regions, the cysteine, and tryptophan residues [36]. By uSe of 
immunoaflinity chromatography, the protein has been purified and 
shown to possess DT activity [37]. This and other advances in the 
molecular biology of TPR-2 and related proteins are covered in 
detail by other contributors in this issue (see Halaban, Kwon, and 
Shibahara). 
Because both DT and metal ions are present in melanocytes, 
efforts have been made to discriminate their effects on the kinetics 
and mode of rearrangement of dopachrome [32,38]. In a vis-a-vis 
comparison [39], using a set of analytical techniques, it was found 
that the enzymic-promoted reaction is highly stereospecific for L­
dopachrome, is unaffected by EDT A, and has an optimal pH of 
about 6.7. By contrast, the kinetics of the metal {Cu++)-catalyzed 
rearrangement are not dependent on the stereochemistry of the 
substrate, are affected by EDTA, and are not influenced by the pH of 
the medium in the range between 5 and 8. Moreover, the ratio of 
formation of DHICA/DHI determined by HPLC is significantly 
higher in the enzyme-catalyzed than in the metal-catalyzed reac­
tion. 
The relative contribution ofDT and metal ions in the metabolism 
of dopachrome is still an open question, although their activities do 
not seem to be mutually exclusive. In connection, Mishima and 
co-workers [40] have presented evidence that the subcellular distri­
bution of DT in B 16 mouse and hamster melanoma cells, paIallels 
that of tyrosinase, i.e., very high in coated vesicles, low in pre-mel­
anosomes, and absent in melanosomes. This is exactly the opposite 
of what has been recently shown to be the distribution of metal ions, 
such as copper, iron, and zinc, in the subcellular compartments of 
melanocytes from hamster melanoma (see Shibata et ai, p. 222S). 
From a functional viewpoint, another difference is that the activity 
of DTase is mainly directed to convert dopachrome into DHICA, 
whereas with metal ions a significant amount ofDHI is inevitably 
formed. Moreover, metal ions, especially copper, also have other 
catalytic activities, e.g., pseudo-catalase or pseudo-peroxidase activ­
ity, that may play a role in the subsequent polymerization of the two 
indoles to melanochrome(s). 
This step has been traditionally envisaged as the third site of 
intervention of tyrosinase [41,42]. However, considering the 
marked tendency of 5,6-dihydroxyindoles to undergo oxidation, 
one would expect that a high specificity of the assisting enzyme, if 
any, is not required. In keeping with this view, we found that 
peroxidase is by far more effective than tyrosinase in promoting the 
oxidative of DHI to melanochrome. A detailed account of these 
studies has appeared recently [43]. Here, it suffices to note that 
under comparable conditions oxidation of DHI with the peroxi­
dase/HzOz system proceeds almost instantaneously, whereas with 
tyrosinase the reaction is rather slow (Fig 3), with an initial rate of 
4.4 X 1(}5 M/second [44]. 
Even more dramatic is the difference in the relative effectiveness 
of the two enzymes when DHICA is used as substrate. The kinetic 
data (Fig 3) indicate a very poor catalytic effect of tyrosinase (initial 
rate about 5.6 X 1(}6 M/second), in marked contrast with the per­
oxidase system, which again induces a fast and complete conversion 
of DHICA to melanochrome. 
These results, although supporting the involvement of peroxi­
dase in melanogenesis, also provide an explanation for the incorpora­
tion ofDHICA into the pigment polymer, which would otherwise 
be difficult to reconcile with the low oxidizability of this substrate 
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Figarel. Comparison of the rate of oxidation of DHI(upper)andDHICA 
(lower) catalyzed by tyrosinase (A) and peroxidase/H202 (B), as followed 
by HPLC mOnitoring of substrate decay. 
by tyrosinase. Preliminary experiments from my laboratory 
strongly suggest that peroxidase may also play a critical role in the 
biosynthesis of pheomelanins, acting in particular on the oxidative 
polymerization of cysdopas. Like DHICA, cysdopas are very poor 
substrates of tyrosinase, unless a suitable redox cycler such as dopa is 
present in the incubation mixture. 
The biosynthetic implications derived from these in vitro studies 
have been recently integrated by a re-examination of the distribu­
tion of peroxidase in different subcellular compartments of melano­
cytes from hamster melanoma tissues [45]. Interestingly, the high­
est levels of peroxidase activity were found associated with stage II 
and III pre-melanosomes, whereby pigment deposition begins to 
appear. Moreover, no significant peroxidase activity was detected 
histochemically in amelanotic melanoma cells, consistent with the 
putative role of this enzyme in melanogenesis. 
Pheomelanins and Related Metabolites The cytophysiology 
of pheomelanin synthesis has been most extensively investigated in 
the formation of the yellow (agouti) band during hair growth in 
mice [46,47]. An interesting observation, supported by more recent 
studies [48,49], is that tyrosinase activity during pheomelanogenesis 
is lower than in eumelanogenesis. The mechanisms that regulate 
tyrosinase synthesis and processing are also different in eumelanin­
and pheomelanin-forming melanocytes [50]. Moreover, the 
switching from eumelanogenesis to pheomelanogenesis is ac­
companied by a marked overall decrease in the melanin content of 
hair, as indicated by the ratio AHP /PTCA [52]. 
These associations were taken to mean that the level of tyrosinase 
in melanocytes may be a critical factor in the switch mechanism 
leading from eumelanin to pheomelanin synthesis. Such a view, 
160S PROTA 
however, seems to be in contrast wi�h an earlier repo� by King et af 
[53] showing that the enzyme levels m the human folhcular melano­
cytes from red-haired subjects are higher than those
. 
from dark­
haired subjects. Similar results have been recently obtamed by Bur­
chill et al [5 4] upon comparing tyrosinase expression in some 
twenty-three red- and dark-haired subjects. Thus, if it is conceded 
that pheomelanogenesis in mouse hair follicles foll<?ws the same 
pathway as that that occurs �n t�e human c�unterp�t, It wo';lld seem 
that the switching mechamsm IS not assocIated with a specific level 
or change of tyrosinase activity. but rather with �n increased availa­bility of sulfhydryl compounds m the melanogemc compartments of 
the pigment-producing cell, as previously suggested by Prota [55]. 
At the biologic level, an increase in the sulfhydryl content ?f 
pheomelanin-producing melanocytes is well documented both m 
mice and in guinea pig skin [1,2]. Howe.ver, which <?f .
the two 
putative thiols, namely, cysteine or gl�tathlon� (GSH), IS mv?lve� 
in the formation of the cysdopas reqUired for pIgment formation IS 
still an open question. Although the effect of cysteine on the synthe­
sizing activity of melanocytes does not involve any additional enzy­
matic system, the participation of GSH �n the biosynthesis �f pheo­
melanins is more complex, because It apparently reqUIres �he 
intervention of hydrolytic enzymes to release the bound cysteme 
residue after the coupling of the thiol group to the quinone. 
The enzymes, )I-GPT and peptidase, required for this transforma­
tion are of wide occurrence in biologic systems and have also been 
detected in human malignant melanocytes [2 4]. Moreover, M�­
shima and co-workers [5 6,57] found that the level of )I-GPT IS 
higher in melanotic than amelanotic cells. They also obtained evi­
dence that the intracellular distribution of )I-GPT paralleles that of 
tyrosinase, the highest -concentration occurring in coated v�sicles 
rather than in melanosomes. However, the actual role of thIS en­
zyme in the biosynthesis of cysdopas �d the sul�ur-containing 
pheomelanins awaits confirmation. I� thiS co�ne�non, a word of 
caution is in order about the common inferentlal lmk between cys­
dopa formation and pheomelanogenesis. In fact, the two processes 
are not necessarily associated, as evidenced by the occurrence of 
cysdopas in all kinds of melanocytes �ncluding, for �x�mple,. t�ose 
of the adult eye in which the rate of pIgment syntheSIS IS neghglble. 
Indeed, it appears that formation of cysdopa is part of the co�plex 
machinery by which GSH controls the amount of dopaqumone 
available for pigment formation. 
Similar mechanisms of regulation can be envisaged to occur at the 
expense of other melanogenic intermediates such as . dopa. 
chrome 
and 5,6-indolquinone, which are also capable of reactmg With both 
cysteine and GSH under biogenetically relevant conditions. The 
chemistry underlying these reactions is rather complex and has re-
cently been covered in so�e detail [58]. . . . Regarding the conversion of �sdopas to �heomelamns,.'n vItro biosynthetic experiments [2], camed out mainly on the 5-lsomer, 
suggest that the reacti?n i.n��lves the oxi?ative. ri�g �losure o� the cysteine side chain to give Imtlally an o�qumonelffime.m�ermedl�te; this can either give rise to the 1,4-dlhydrobenzothlazmylalanme 
(see Fig 2) by redox exchange with the starting material, or undergo 
rearrangement with or without concomitant decarboxylati?n to 
give a 2H-l,4-benzothiazinylalanine (R- H  or COOH). WhIch of 
these products is prevailing depends upon various parame�ers, such 
as pH, oxygen tension, and notably the presence of metal l?ns [59]. 
There is evidence that suggests that 2-cysdopa and 2,5-dlcysdopa 
behave similarly, but little is definitely known about the later stages 
of the biosynthesis of pheomelanins and the chemically related tri­
chochromes. Investigation is complicated by the instability of the 
various benzothiazine intermediates involved, and by the fact that 
many concurrent reactions can take place. Using 13C_, 14C_, 35S_ and 
tritium-labeled cysdopa precursors, Deibel and Chedekel [60,61] 
obtained evidence suggesting that during polymerization a small 
percentage of the benzylic carbon of the alanine side chain under­
goes oxidation to an olefinic or aromatic type carbon, whereas. the majority exhibits no change in oxidation state or attache� fu�cnon­
ality. Moreover, the 13C nmr spectrum of the pheomelanm pigment 
prepared from oxidation of 5-cysdopa labeled on the carboxyl group 
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of the cysteine side chain indicates that the incorporated carbon is 
still in the form of carboxylic acid moieties. However, apart from 
these and other structural details, the mode of polymerization of the 
posrulated benzothiazine intermediate(s) remained elusive and 
awaits further srudies. 
CONCLUSION 
In this short review I have attempted to give a representative picture 
of the giant steps made in recent years toward the understanding of 
the chemistry of melanins and melanogenesis. To an unusual ex­
tent, most of what has been achieved has resulted from a chemical 
approach involving direct analysis of natural pigments coupled with 
srudies of the chemical reactivity of the putative intermediates 
under biologically relevant conditions. Thus, bit by bit it has been 
possible to reconstruct in vitro the overall chemical activity of mela­
nocytes and to predict the existence of a number of biosynthetic 
intermediates and control points. We also owe much to the power­
ful investigative methods of molecular biology, which have allowed 
a new appreciation of the enzymatic regulation of melanogenesis. If 
the molecular approach to the melanocyte function is valid and a 
viable one, as seems to be the case, consideration of the reaction 
pathways outlined in Fig 2 should then provide a useful background 
to identify the pigment-related genes that control the biochemical 
steps of melanogenesis and others that operate via the milieu in 
which the melanocyte resides. Such srudies have been begun in 
some laboratories, but more remain for chemists and biologists of all 
specialities. Their efforts will be all the more effective if each un­
derstands the concepts and approaches of his colleagues. I hope that 
the proposed scheme highlighting the overall chemical activity of 
melanocytes will help in achieving this goal. 
This work was carried out in the frame of the BC Project "New Strategies and 
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sira e della Ricerca Scientifica e Tecnologica, and the CNR, Progetto Chimica Fine 2 
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